Table 5. Survival figures in various series that utilized EPP or P/D as surgical treatment.

Author and year	Type of surgery, histology	Type of treatment	Number of patients (n)	Median survival (months)	2-year survival rate (%)	5-year survival rate (%)
Rimner, 2016 (21)	P/D, all	Neoadjuvant chemotherapy, adjuvant pleural IMRT	27	23.7	59	NA
Batirel, 2016 (8)	EPP, P/D, exploratory, all	Trimodality treatment	130	17.8	32	14
Lang-Lazdunski, 2015 (10)	P/D, all	Neoadjuvant and adjuvant chemotherapy	102	32	63	23
Stahel, 2015 (23)	EPP, all	Neoadjuvant and adjuvant treatment	151	15	NA	NA
Spaggiari, 2014 (12)	EPP, all	Neoadjuvant and adjuvant therapy	518	18	41	14
Sugarbaker, 2014 (24)	EPP, epithelioid	Multimodality treatment	529	18	39	14
Bölükbas, 2013 (22)	Extended P/D, all	Adjuvant chemoradiation	78	32	NA	25
Gomez, 2013 (15)	EPP, All	Adjuvant hemithoracic IMRT	136	14.7	32	NA
Flores, 2008 (6)	EPP, P/D, all	Multimodality treatment	663	14	NA	12